International Journal of Contemporary Pediatrics

Prasad GS et al. Int J Contemp Pediatr. 2017 Jul;4(4):1554-1556

http://www.ijpediatrics.com

pISSN 2349-3283 | eISSN 2349-3291

Bronze baby syndrome an infrequent complication of phototherapy: a case report

G. Shiva Prasad, B. Sri Lalitha Savithri, Sadasiba Padhy, Rajesh Kumar Sethi*


Department of Pediatrics, Konaseema Institute of Medical Science and RF, Amalapuram, Andhra Pradesh, India

Received: 09 May 2017

Accepted: 03 June 2017

*Correspondence:

Dr. Rajesh Kumar Sethi,

E-mail: raj4alll@gmail.com

Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

ABSTRACT

Phototherapy is a common mode of treatment for neonatal hyperbilirubinemia. Bronze baby syndrome is an infrequent complication of phototherapy. The characteristic feature is a grayish-brown discoloration of the skin, plasma and urine. The pigment responsible for the discoloration has not been properly identified and pathogenesis remains still unelucidated. The bronze color disappears spontaneously and the findings are compared to other causes of dusky-hued skin in the neonate. The bronze baby syndrome is usually innocuous but can signal life-threatening disease for which investigations should be performed routinely.

Keywords: Bronze baby syndrome, Neonatal hyperbilirubinemia, Phototherapy

INTRODUCTION

Neonatal jaundice is a very common problem in first 2 weeks of life and phototherapy is the usual mode of treatment. Bronze baby syndrome is a less common complication of phototherapy. Bronze baby syndrome is the greyish brown pigmentation of skin, mucous membrane, and urine following phototherapy.1 It is assumed that abnormal accumulation of photoisomer of bilirubin and hepatic dysfunction leading to copper porphyrin complex which is photo destroyed during phototherapy leading to brown pigmentation of the skin and mucous membrane.2 Sometimes accumulation of biliverdin may also cause this brown pigmentation. It is probably due to a reduction in hepatic excretory function of bilirubin photoproducts.3,4

CASE REPORT

A term 2.49 kg birth weight, female neonate was born to a 29-year-old multipara mother by LSCS in our hospital. Baby is a product of consanguineous marriage. Antenatal period was uneventful. She cried immediately after birth and didn’t require any resuscitation. Baby was noticed to have yellowish discoloration of eye and skin on day 2 of life. Serum total bilirubin level was 16.4 mg/dl with direct bilirubin 1.1 mg/dl. She was treated with single surface phototherapy. Serum bilirubin level increased on next day to a total bilirubin of 18.9 mg/dl with direct component 1.4 mg/dl. So, baby was put under double surface phototherapy. Later towards the end of the day it was noticed that she had a greyish brown discoloration of the entire body (Figure 1).

Phototherapy was continued for 48 hours and was stopped when bilirubin level was below phototherapy range. She was diagnosed to have bronze baby syndrome and was evaluated for a possible cause. She was passing dark colored urine and dark yellow colored stool. Her liver function tests results were within normal range Ultrasonogram (USG) of the abdomen was performed to rule out any liver and biliary pathology which was normal. Baby’s metabolic parameters were also normal with a normal blood sugar. Her urine was negative for reducing substances. HIDA scan was also normal. CBC result showed Hb=13.2 and rest of the values being normal. Reticulocyte count was 6%.

Figure 1: Greyish brown discoloration of skin during phototherapy.
Figure 1: Greyish brown discoloration of skin during phototherapy.
Figure 2: Normal skin color after 3 weeks.
Figure 2: Normal skin color after 3 weeks.

There is ABO incompatibility in blood grouping with blood group of mother being O+ve and that of baby is B+ve.

Figure 3: Brownish dark color urine during phototherapy.
Figure 3: Brownish dark color urine during phototherapy.

In peripheral smear, there were no signs of hemolysis. After 48 hr of phototherapy serum bilirubin level was 8.9 mg/dl with direct bilirubin being 1.1 mg/dl which was below phototherapy range. So, baby was discharged and kept in regular follow up. After 3 weeks of discharge there was spontaneous disappearance of the greyish brown pigmentation of the skin with a normal urine color.

Figure 4: Normal color urine in follow up.
Figure 4: Normal color urine in follow up.

DISCUSSION

It is assumed that abnormal accumulation of photoisomer of bilirubin is the cause of bronze baby syndrome.2 The second cause postulated is abnormal hepatic function leading to copper porphyrin complex which is photo destroyed leading to brown pigmentation.3

The third explanation is an accumulation of biliverdin leading to brown pigmentation. It is probably due to a reduction in hepatic excretory function of bilirubin photoproducts. The pigment accumulated in the body may be polymerized and forms bilifuscin like substances following a free radical reaction.2 It should be differentiated from gray baby syndrome exclusively seen in neonates and very young infants receiving high doses of chloramphenicol with clinical features of cyanosis, acidosis, cold peripheries and marked hypotonia.6

No treatment is usually required for bronze baby syndrome as the pigmentation slowly disappears after stopping phototherapy.5 The prognosis of bronze baby syndrome depends on the causative liver diseases like bile duct atresia, galactosemia and parenteral nutrition with cholestasis for which investigations should be performed routinely.6

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient’s parents have given their consent for their baby’s images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: Not required

REFERENCES

  1. 1. Kopelman AE, Brown RS, Odell GB. The Bronze Baby syndrome: a complication of phototherapy. J Pediatr. 1972;81:466.
  2. 2. Onishi S, Itoh S, Isobe K, Togari H, Kitoh H, Nishimura Y. Mechanism of development of bronze baby syndrome in neonates treated with phototherapy. Pediatrics 1982;69:273‑6.
  3. 3. Rubaltelli FF, Jori G, Reddi E. Bronze Baby syndrome: a new porphyrin-related disorder. Pediatr Res. 1983;17:327-330.
  4. 4. Cuvellier JC, Gottrand F, Largillière C, Farriaux JP. The bronze baby syndrome apropos of 3 cases. Ann Pediatr (Paris). 1990;37:669‑71.
  5. 5. Tan KL, Jacob E. The Bronze Baby Syndrome. Acta Pediatr Scand. 1982;71(3):409-14.
  6. 6. Kadam RM, Prasad V. Bronze baby: A rare presentation of biliary atresia. Indian J Pediatr Dermatol. 2016;17:199-201.